Clinical Trials in Tennessee

Showing 3401-3420 of 9,675 trials

Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing

NCT04213326

This is a prospective, observational study of 1,000 subjects with known or suspected cancer and 2,000 subjects with no known cancer. Potential participants will be asked questions to confirm their eligibility by a nurse navigator, study staff member, or physician. Informed consent will be carried out for eligible subjects in accordance with applicable federal regulations and International Council for Harmonisation (ICH)/Good Clinical Practice (GCP) guidelines. Subjects will then complete a survey, and study staff will draw 60 mL of blood and measure the height and weight of the subject. Where available, data from the medical records of the cancer subjects will reviewed and collected. In addition, non-cancer subjects will be requested to allow access to their medical records as an optional portion of their informed consent.

Early Cancer Detection

Exact Sciences Corporation6,400 participantsStarted Nov 2019

Thousand Oaks, California, United States • Denver, Colorado, United States • Fort Walton Beach, Florida, United States +11 more locations

TERMINATEDPhase 129 miles

Study of ADCT-301 in Patients With Selected Advanced Solid Tumors

NCT03621982

This study evaluates ADCT-301 in patients with Selected Advanced Solid Tumors. Patients will participate in a Treatment Period with 3-week cycles and a Follow-up Period every 12 weeks for up to 1 year after treatment discontinuation.

Head and Neck Cancer Squamous Cell CarcinomaNon-small Cell Lung CancerGastric Cancer+9 more

ADC Therapeutics S.A.78 participantsStarted Nov 2018

Palo Alto, California, United States • New Haven, Connecticut, United States • Portland, Oregon, United States +6 more locations

Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing

Study of ADCT-301 in Patients With Selected Advanced Solid Tumors

Find Trials by Condition in Tennessee

Bridge to HOPE: Hypothermic Oxygenated Perfusion Versus Cold Storage Prior to Liver Transplantation

Trim II for Noninvasive Lipolysis and Circumference Reduction of Abdomen.

Tolerability, Safety and Efficacy of a New Frequency of Vibrant Capsule Administration

A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat

A Study of TAK-981 Given With Rituximab in Adults With Relapsed or Refractory CD20-Positive Non-Hodgkin Lymphoma

HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate Cancer

Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic Dermatitis

Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy

Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations

Improving Veteran Adherence to Treatment for PTSD Through Partnering With Families

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)

A Study to Evaluate LB1148 for Return of Bowel Function in Subjects Undergoing Bowel Resection

Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)

Trial for Treatment Refractory Trigeminal Neuralgia

A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3

Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

A Study of Replagal in Treatment-naïve Adults With Fabry Disease